Results 121 to 130 of about 15,537 (248)

Rituximab in the Management of Autoimmune Bullous Diseases: A Treatment-Resistant Case Series from a Single Central European Referral Center

open access: yesMedicina
Background and Objectives: Rituximab (RTX) has been the predominant treatment for autoimmune bullous diseases (AIBDs). The objective of this research was to assess the advantages and safety characteristics of RTX treatment in individuals with AIBD.
Maciej Marek Spałek   +3 more
doaj   +1 more source

Desmoglein autoimmunity in the pathogenesis of pemphigus

open access: yesAutoimmunity, 2006
The most characteristic feature of pemphigus is a loss of cohesion between keratinocytes, resulting in formation of blisters and erosions on the mucosal membranes and the skin. Identification of circulating antibodies which bind to desmogleins (Dsg), transmembrane proteins involved in assembly of the desmosomes, led to the immediate realization that ...
openaire   +2 more sources

Ectopic Lymphoid Structures Harbor Desmoglein-Specific B Cells in the Chronic Skin Lesions of Patients with Pemphigus

open access: gold, 2019
Dawoon Han   +5 more
openalex   +1 more source

Author response: E-cadherin binds to desmoglein to facilitate desmosome assembly

open access: gold, 2018
Omer Shafraz   +6 more
openalex   +1 more source

Pemphigus foliaceus presenting with violaceous, painful nodules and an aberrant auto-antibody expression in a Latino patient

open access: yesJAAD Case Reports, 2021
Jeffrey N. Li, BS, BBA   +4 more
doaj   +1 more source

Spectrum of dominant mutations in the desmosomal cadherin desmoglein 1, causing the skin disease striate palmoplantar keratoderma [PDF]

open access: bronze, 2001
DebbieM Hunt   +15 more
openalex   +1 more source

Evaluation of the Ultrastructure and Expression of Desmoglein 2 in Breast Cancer: A Novel Biomarker [PDF]

open access: green, 2021
Maryam Mohammadhosseini   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy